Background: The maternal health of women who use alcohol and other drugs (AOD) in pregnancy is poorly described. This study examines those associations, as well as maternal and neonatal outcomes.
Methods: This was a retrospective cohort study using data collected by pregnancy care providers from four NSW Local Health Districts from 2017 to 2020. We identified women with a substance use disorder (SUD), women with significant AOD use but not an SUD, and women who used tobacco only. We examined a range of physical, mental and reproductive health factors and explored associations with maternal and neonatal outcomes.
Results: From 57475 mothers, 454 had a SUD (0.8%), 1155 (2.0%) had significant AOD use, 3880 (6.8%) used tobacco only. Compared to women with low level alcohol or no AOD use, women with all other patterns of AOD use had higher Edinburgh depression scores, more iron-deficiency anaemia, more musculo-skeletal and respiratory diseases, and lower cervical screening rates. The women had longer length of stay (LOS) (aOR 1.46-4.16) and their babies had increased odds of being small for gestational age (aOR 2.06-3.87), preterm birth before 37 completed weeks (aOR 1.52-2.69), 5-minute Apgar scores < 7 (aOR 1.32-2.03), child protection involvement (aOR 3.85-10.63), and longer LOS (aOR 1.62-4.47).
Conclusions: Women with all patterns of AOD use had poorer baseline maternal health and worse perinatal outcomes. These women need access to multidisciplinary holistic pregnancy care including obstetric and drug health support.